ANXA6 and breast carcinoma: The proinvasive activity of AnxA6 is further reinforced by the identification of a monoclonal antibody (9E1) against AnxA6 with anti-invasive properties on several aggressive cancer cells including pancreatic, lung squamous and breast cancer cells [94].